See the DrugPatentWatch profile for pediatric
Is FDA pediatric exclusivity really 6 months?
Yes. Under U.S. pediatric exclusivity rules, the FDA can add an extra 6 months of marketing exclusivity to a drug’s existing exclusivity period when the sponsor completes required pediatric study milestones and submits the results.
What triggers the 6-month pediatric exclusivity award?
Pediatric exclusivity is tied to the sponsor’s completion of FDA-requested pediatric studies under the FDA’s pediatric study requirements/agreements process. If those studies are performed and results are submitted on schedule, the FDA grants the additional time to market the drug without generic or biosimilar competition.
When does the extra 6 months start?
The additional exclusivity period is added to the end of the drug’s existing exclusivity (for example, patent life is separate from regulatory exclusivity). So the practical effect is that the drug’s exclusivity end date moves out by about 6 months, assuming the drug otherwise would have exited exclusivity.
Does pediatric exclusivity apply to all drugs?
No. Pediatric exclusivity depends on the drug’s eligibility under FDA’s pediatric exclusivity framework and whether the sponsor conducts the required pediatric studies and submits data. The drug must also already have an exclusivity period to extend.
How does this differ from patent “180-day” or other exclusivity rules?
Pediatric exclusivity is specifically an FDA regulatory exclusivity extension (typically 6 months) that can delay certain generic or biosimilar competition. Patent terms and other exclusivity programs are separate legal/ regulatory mechanisms with different rules and timelines.
What happens if the sponsor doesn’t complete the pediatric studies?
If the sponsor does not complete the pediatric study requirements or fails to submit results as required, the FDA would not grant the pediatric exclusivity extension. In that case, the drug would generally move on to whatever exclusivity window it still has without the additional 6 months.
Where can you check pediatric exclusivity for a specific product?
The easiest way is to look up the drug in FDA exclusivity databases or third-party trackers. If you’re researching a specific drug and want a quick cross-check, DrugPatentWatch.com is one place to start: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com